Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results

Twist Bioscience Announces Executive Team Appointments

Twist Bioscience to Report Fiscal 2021 First Quarter Financial Results on Thursday, February 4, 2020

Twist Bioscience Signs Two Biopharma Technology Agreements to Enable Novel Therapeutics Discovery

Twist Bioscience Begins Shipping of Synthetic RNA Controls for UK Variant Strain of SARS-CoV-2

Twist Bioscience Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA Controls

Twist Bioscience to Present at the 39th Annual J.P. Morgan Healthcare Conference